Precision Breaks at Activation: Making Advanced Audience Targeting Possible with Throtle

Sarah Heming
VP of Strategic Marketing at Diaceutics
Brand Strategy

In pharma marketing, diagnostic intelligence is only as valuable as a team’s ability to use it. Yet this is where even the most advanced audience targeting strategies often falter. Clinical cohorts get defined and insights surface. And yet, activation stalls, slowed by identity gaps, onboarding delays, privacy concerns, and operational friction. All this keeps programs from ever reaching their full potential.

Our latest partnership with Throtle combines our clinical audiences with their privacy-first resolution. It enables pharma teams to move from insight to activation without friction. Making precision not just a promise but something teams can confidently use at scale. And without the bottlenecks that typically undermine precision execution.

When working with diagnostic-driven audiences, compliance and scalability is of utmost importance. Advanced audience targeting is only powerful if it can be connected to the right HCP.

 
Why Precision Breaks at Activation

Most pharma marketers know this story well:

  • Audience design is rich and clinically aligned. It is often rooted in genomics, lab results, and real-world diagnostic patterns.
  • Identity data lags behind. This leaves marketers unable to match those insights to real, reachable HCPs. Or at least in a compliant, privacy-safe way.
  • The result? Activation is fragmented, delayed, or scaled back. Precision promise in, blunt execution out.

This bottleneck represents the single biggest barrier between what precision could deliver and what actually reaches the field.

 
Where Diaceutics and Throtle Close the Gap

Our collaboration marries our complementary strengths:

 

1. Diaceutics: Diagnostic-Powered Clinical Audience Intelligence

We use deep lab, genomic, claims, EHR, and pharmacy data to build clinical cohorts focused on true patient journeys at the molecular level. This advanced audience targeting delivers the precision marketers need for effective omnichannel execution.

 

2. Throtle: Privacy-First Healthcare Identity Resolution

Throtle unifies fragmented identity data - securely and compliantly. They connect clinical insights to verified HCP identities and digital channels.

Together, these capabilities make precision audiences usable, activatable, and scalable.

 
Turning Insights Into Confident Activation

With a single, integrated solution, pharma marketers can now:

  • Resolve identity gaps that traditionally slow onboarding
  • Activate clinical segments without compliance trade-offs
  • Reach HCPs across channels with more accuracy and less friction
  • Execute omnichannel programs that actually reflect clinical reality

 

This collaboration fundamentally reshapes how brands connect with healthcare providers across digital channels. Throtle’s identity layer ensures that even highly advanced diagnostic-based cohorts translate directly into actionable, measurable HCP audiences.

 
Precision Moves From Promise to Practice

Our partnership is helping pharma marketers under pressure. Our advanced audience targeting makes it easier than ever to personalize, differentiate, and make an impact. Together, we're helping remove the biggest barrier to success: the activation gap.

When clinical cohort design and privacy-first identity resolution finally work together, precision medicine marketing stops being aspirational and becomes operational.

Insight without friction. Activation without hesitation. Precision without limits.

Register your interest in Diaceutics Audiences today.

What is the Diaceutics and Throtle partnership?

The partnership combines Diaceutics' diagnostic-powered clinical audiences with Throtle's privacy-first healthcare identity resolution. It lets pharma marketers move from insight to activation without friction. Precision audiences become usable, activatable and scalable.

Why does precision audience targeting break down at activation?

Audience design is often rich and clinically aligned, rooted in genomics, lab results and real-world diagnostic patterns. But identity data lags behind. Marketers can't match those insights to real, reachable HCPs in a compliant, privacy-safe way. Activation ends up fragmented, delayed or scaled back.

What is the activation gap in pharma marketing?

The activation gap is the distance between the precision insights that clinical cohorts can deliver and what actually reaches the field. It is caused by identity gaps, onboarding delays, privacy concerns and operational friction. It is the single biggest barrier to effective precision marketing.

How do you connect diagnostic-based audiences to verified HCPs?

Diaceutics builds clinical cohorts from lab, genomic, claims, EHR and pharmacy data. Throtle then unifies fragmented identity data, securely and compliantly. It connects those clinical insights to verified HCP identities and digital channels.

How can pharma teams activate clinical segments while staying compliant?

Throtle's privacy-first identity resolution lets teams activate clinical segments without compliance trade-offs. Advanced audience targeting is only powerful if it can be connected to the right HCP. The compliant connection is what makes diagnostic-driven audiences practical at scale.

What can pharma marketers do with Diaceutics and Throtle together?

With a single integrated solution, marketers can:

  • Resolve the identity gaps that slow onboarding
  • Activate clinical segments without compliance trade-offs
  • Reach HCPs across channels with more accuracy and less friction
  • Run omnichannel programs that reflect clinical reality
Written By Sarah Heming
Sarah Heming is Interim VP of Strategic Marketing at Diaceutics, where she leads brand strategy and global marketing to help pharma and biotech partners bring diagnostic-driven therapies to more eligible patients. A senior marketing and communications leader with more than two decades across Fortune 500 and highly regulated industries, she has driven transformative growth, award-winning product launches and high-impact corporate rebrands. Sarah previously held marketing leadership roles at Zoetis, Mölnlycke Health Care and Abbott, bringing deep expertise in brand building, stakeholder engagement and omnichannel strategy.
Read more by this author
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.